RMD shares: your next growth investment?
Rask Invest Research Team
November 4, 2024
The Resmed CDI (ASX:RMD) share price is up 46.7% since
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
The Resmed CDI (ASX:RMD) share price is up 46.7% since
The Resmed CDI (ASX:RMD) share price has increased 44.4% since
Want to value the Resmed CDI (ASX:RMD) share price? Here
The ASX Ltd (ASX:ASX) share price is up 6.2% since
Is the Resmed CDI (ASX:RMD) share price cheap? Here are
The Resmed CDI (ASX:RMD) share price is up 41.7% since
The ASX Ltd (ASX:ASX) share price has risen 4.9% since
The Resmed CDI (ASX:RMD) share price has increased 40.5% since
The Resmed CDI (ASX:RMD) share price is up 38.6% since
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.